✦ LIBER ✦

Catechol-O-methyltransferase inhibitors in Parkinson's disease

✍ Scribed by J Harper; B Vieira

Book ID: 117298001
Publisher: The Lancet
Year: 1998
Tongue: English
Weight: 18 KB
Volume: 352
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)79290-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Catechol-O-methyltransferase inhibitors

Catechol-O-methyltransferase inhibitors in Parkinson's disease

✍ Colm Henry; JA Wilson 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 54 KB

Catechol-O-methyltransferase inhibitors

Catechol-O-methyltransferase inhibitors in Parkinson's disease

✍ Tao Xie; Shu-Leong Ho; David Ramsden 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 46 KB

New, Selective Catechol-O-Methyltransfer

New, Selective Catechol-O-Methyltransferase Inhibitors as Therapeutic Agents in Parkinson’s Disease

✍ Vincenzo Bonifati; Giuseppe Meco 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Catechol-O-methyltransferase inhibitors:

Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease

✍ Jasper Dingemanse 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 2 views

Substitution therapy with levodopa and a peripheral inhibitor of aromatic L-amino acid decarboxylase (AADC) is the cornerstone in the treatment of Parkinson's disease. Chronic therapy with levodopa, however, is associated with the occurrence of motor complications that are partially related to the p

Catechol-O-methyltransferase inhibitors:

Catechol-O-methyltransferase inhibitors: their role in the therapy of Parkinson's disease (PD)

✍ M. Da Prada 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Effects of tolcapone, a catechol-O-methy

Effects of tolcapone, a catechol-O-methyltransferase inhibitor, on motor symptoms and pharmacokinetics of levodopa in patients with Parkinson's disease

✍ M. Yamamoto; M. Yokochi; S. Kuno; Y. Hattori; Y. Tsukamoto; H. Narabayashi; H. T 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 517 KB